*	OR T4 T5
R1	Has_qualifier Arg1:T4 Arg2:T6	
R2	Has_temporal Arg1:T4 Arg2:T8	
*	OR T7 T11
*	OR T15 T17 T16
R3	Has_value Arg1:T15 Arg2:T13	
R4	Has_temporal Arg1:T15 Arg2:T14	
*	OR T20 T21
R5	Subsumes Arg1:T22 Arg2:T23	
*	OR T18 T19
R6	Has_temporal Arg1:T18 Arg2:T20	
R7	Has_temporal Arg1:T18 Arg2:T22	
*	OR T27 T28
R8	Has_temporal Arg1:T27 Arg2:T31	
R9	Has_temporal Arg1:T27 Arg2:T32	
*	OR T36 T37
R10	AND Arg1:T34 Arg2:T36	
R11	Has_temporal Arg1:T29 Arg2:T31	
R12	Has_temporal Arg1:T30 Arg2:T31	
R13	Has_temporal Arg1:T29 Arg2:T32	
R14	Has_temporal Arg1:T30 Arg2:T32	
T1	Temporal 22 36	within 28 days
T2	Context_Error 0 63	Recent participation (within 28 days) in other research studies
T3	Post-eligibility 0 63	Recent participation (within 28 days) in other research studies
T4	Procedure 84 98	blood donation
T5	Procedure 102 117	plasma donation
T6	Qualifier 72 83	significant
T8	Temporal 65 71	Recent
T10	Undefined_semantics 72 83	significant
T7	Condition 119 127	Pregnant
T11	Condition 131 140	lactating
T13	Value 147 155	positive
T14	Temporal 156 168	at screening
T15	Measurement 173 207	human immunodeficiency virus (HIV)
T16	Measurement 249 272	hepatitis C virus (HCV)
T17	Measurement 209 244	hepatitis B surface antigen (HbsAg)
T18	Condition 313 323	alcoholism
T19	Condition 327 337	drug abuse
T20	Temporal 290 297	history
T21	Mood 301 309	evidence
T22	Temporal 274 280	Recent
T23	Temporal 282 288	2-year
T26	Post-eligibility 339 550	History or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease
T27	Drug 579 584;599 615;626 655	drugs known to inhibit cytochrome (CYP) P450 enzymes
T28	Drug 579 584;599 607;619 655	drugs known to induce cytochrome (CYP) P450 enzymes
T29	Drug 579 584;599 615;663 684	drugs known to inhibit P-glycoprotein (P-gp)
T30	Drug 579 584;599 607;619 625;663 684	drugs known to induce P-glycoprotein (P-gp)
T31	Temporal 685 723	within 28 days prior to the first dose
T32	Temporal 728 748	throughout the study
T34	Condition 755 764	allergies
T36	Drug 768 783	quinine sulfate
T37	Drug 787 800	rosiglitazone
